LILLY FUNG: Open Payments
NPI 1548540727 · SAN LEANDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $124 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| Novo Nordisk Inc | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
Products named: Kerendia, AIRSUPRA, FARXIGA, ZENPEP, ZORYVE, JARDIANCE, LINZESS, Ozempic.
Industry payments across CA — which companies pay providers there.
